Annals of Clinical Pathology

Age-Period-Cohort Analysis of Mesothelioma: Flat Incidence Trends for Males Entering US Workforce After 1972

Research Article | Open Access

  • 1. Exponent Inc, Irvine CA, USA
  • 2. Optum, Los Angeles, CA, USA
  • 3. Exponent Inc, Alexandria, VA, USA
+ Show More - Show Less
Corresponding Authors
Brent D. Kerger, Exponent Inc, 15615 Alton Parkway, Suite 350, Irvine, CA 92618, USA

This study investigates the hypothesis that US government regulations on occupational asbestos exposures starting in 1972 caused a cohort inflection point after which mesothelioma incidence was flat for males subsequently entering the workforce. An age-period-cohort analysis of the SEER 8 cancer registries (1975-2019) was conducted using five-year intervals of age, calendar period, and birth cohort to evaluate US male incidence of all mesothelioma, as well as pleural, or peritoneal mesothelioma. Work cohort year was defined as birth cohort plus 18 years. Average percent change analysis was used to further evaluate period effects. Age- and period-adjusted work cohort rate ratios (RR) for all mesothelioma, and for pleural mesothelioma, were significantly elevated for work cohorts between 1920 and 1972 with subsequent decreased/flat trends. Similar age- and period-adjusted analysis of peritoneal mesothelioma showed non-significantly elevated work cohort RR between 1920 and 1954 with flat/not elevated incidence trends for work cohorts after 1954. Average percent change trend analyses showed statistically significant period effects on incidence rate trends for all mesothelioma and pleural mesothelioma, but not peritoneal mesothelioma; mesothelioma groups demonstrated significant longitudinal age trends. The cohort of US males first entering the workforce after 1972 shows no increased incidence of pleural mesothelioma. These trends may be related to the impacts of occupational asbestos regulations that took effect in 1972 in addition to plausible threshold dose-dependent risks from chrysotile asbestos which continued to be used through the 1990s. In contrast, US male workers first entering the workforce after the mid-1950s showed no increased risk of peritoneal mesothelioma which has been predominantly associated with amphibole asbestos exposures used in shipbuilding in the era of World War II. The flattening of work cohort mesothelioma rates after 1972 suggests the era of prominent risks from occupational asbestos exposure has ended; continuing incidence may be attributable to non-asbestos etiologies.


Cancer incidence, Pleural mesothelioma, Peritoneal mesothelioma, Asbestos-related mesothelioma, Non-Asbestos-related mesothelioma, Spontaneous mesothelioma


Kerger BD, Odo NU, Loccisano AE (2023) Age-Period-Cohort Analysis of Mesothelioma: Flat Incidence Trends for Males Entering US Workforce After 1972. Ann Clin Pathol 10(1):


The commonly considered etiology of malignant pleural mesothelioma is occupational asbestos exposure, although the disease can also arise due to exposures to erionite, noncommercial amphiboles, ionizing radiation, or aging, and from genetic predisposition or spontaneous occurrence [1,2]. In the past 3 decades, pleural mesothelioma incidence data from the SEER program revealed a peak male age-adjusted rate occurring in the early 1990s and a subsequent decline [3-5]. Age-periodcohort analysis revealed that this pleural mesothelioma trend involved the superposition of strong age-related and birth cohort-related trends that were most prominently impacted by large worker populations exposed to high dose amphiboles during shipbuilding in the World War II era [2].

In contrast to pleural mesothelioma, peritoneal mesothelioma is approximately ten-fold less prevalent among males than pleural mesothelioma, it is more specifically associated with high dose amphibole asbestos, and it often occurs among individuals without known asbestos exposures [3,6]. Peritoneal mesothelioma among US males has shown essentially flat incidence trends for the past 3 decades and occurs more frequently among females and at earlier onset for both sexes [5-7]. Peritoneal mesothelioma risk is demonstrated to be a high cumulative dose phenomenon with excess risk following a threshold-dependent dose-response relationship and occurring predominantly among amphiboleexposed workers with asbestosis and very high lung fiber burdens typically over 100 f/cc*years [8-19]. The Occupational Safety and Health Act of 1970 was promulgated by US Congress in 1970 which formed the Occupational Safety and Health Administration and led to issuance of emergency temporary standards for occupational asbestos exposure in 1971 that became effective in 1972 (Title 29, Code of Federal Regulations). This study investigates the hypothesis that the US government regulations on occupational asbestos exposures starting in 1972 caused an inflection point after which mesothelioma incidence was flat for males subsequently entering the workforce. This hypothesis is investigated by conducting an age-period-cohort analysis of males within the SEER 8 cancer registries (1975–2019).


The incidence data among males for all primary malignant mesothelioma (International Classification of Diseases for Oncology, 3rd edition, histology codes 9050-9055, all sites), and separately for only peritoneal mesothelioma (site codes C48.0 – C48.8), and pleural mesothelioma (site codes C38.4 and C38.8), was obtained from the U.S. Surveillance, Epidemiology, and End Results (SEER) 8 population-based cancer registries from 1975 through 2019; certain comparisons also integrated the available data on SEER-12 and SEER-17, but only SEER-8 data provided the temporally congruous cancer incidence data required for this analysis between 1975 and 2019. Only male cancer incidence data were evaluated based on the predominantly male US workers in asbestos-exposed occupations historically. Data were extracted by 5-year age and calendar-year groups. Data were accessed using SEER*Stat software version after execution of the SEER data use agreement, which includes compliance with ethical and privacy considerations and allows use of the cancer incidence data without separate requirements for study subject consent or Institutional Review Board approval.

The National Cancer Institute (NCI) web tool for age-periodcohort (APC) analysis was applied as described by Rosenberg et al., [20]. The NCI APC web tool enables analysis of net drift (annual percentage change in the expected age-adjusted rates over time), local drifts (annual percentage change in the expected age-specific rates over time), fitted temporal trends (expected rates over time in the reference age group, adjusted for cohort effects), cross-sectional age curve (expected age-specific rates in the reference calendar period, adjusted for cohort effects), longitudinal age curve (expected age-specific rates in the reference birth cohort, adjusted for period effects), period rate ratios (ratio of age-specific rates in each calendar period relative to the reference period), and cohort rate ratios (ratio of age-specific rates in each birth cohort relative to the reference cohort). The NCI APC web tool also enables statistical testing of several null hypotheses related to the stability, log-linearity, and equality of observed trends. Default reference groups were used for comparisons, i.e., for the median calendar period and for the median birth cohorts. The work cohort was estimated by adding the age of typical full time work force entry among US males (age 18) to the birth cohort year, assuming that each individual first enters the workforce at 18 years of age.


Overall, the incidence of all mesothelioma and the predominant subset of pleural mesothelioma showed a work cohort peak in the 1940s and have declined since 1975 with average percent change estimates showing the most significant downward trend of all mesothelioma from 2000 to 2019 for SEER-17 data (Table 1). As expected, this trend is closely mirrored by the incidence trend of pleural mesothelioma, with a significant downward trend in the last two decades (-3.0; 95% CI: -3.6 to -2.4). A similar analysis of peritoneal mesothelioma incidence data (1975-2019) showed a comparatively nominal but statistically significant downward trend (-0.8; 95% CI: -1.5 to -0.1) for the temporally congruous data in SEER-8 (Table 1).

Table 1: Summary of peak mesothelioma average percentage change trends

Cohort Period All mesothelioma Pleural mesothelioma Peritoneal mesothelioma
SEER-8 1975-2019 -0.4 -0.5 -0.8*
SEER-12 1992-2019 -2.1* -2.3* -0.8
SEER-17 2000-2019 -2.7* -3.0* -0.9

Percent changes were calculated using 1 year for each end point; average percent changes were calculated using weighted least squares method. * – Change is significantly different from zero (p<0.05).

Table 2 presents the age-period-cohort analysis parameters segregated by all mesothelioma, pleural mesothelioma, and peritoneal mesothelioma incidence data sets in SEER-8. Period effects showed their peak for all groups between 1979 and 1983. However, only incidence rates for all mesothelioma and pleural mesothelioma showed significant downward net drift (annual percentage change in expected age-adjusted rates over time), and in period rate ratios (the significant ratio of age-specific rates in each calendar period relative to the reference period [1994- 1998]). All mesothelioma groups demonstrated significantly different cohort incidence rate ratios from the median referent group, with significant non-linear age deviation of incidence trends (Table 2).

Table 2: Summary of age-period-cohort analysis for mesothelioma incidence in men across all, pleural and peritoneal mesothelioma cohorts

Age-Period-Cohort Analysis Parameters All mesothelioma Pleural mesothelioma Peritoneal mesothelioma
Period effect: peak incidence      
Incidence years 1979 - 1983 1979 - 1983 1979 - 1983
Net drift % per year -1.50% -1.80% -0.40%
(95% CI) (-2.7 to -0.4) (-3.2 to -0.4) (-2.0 to 1.2)
p-value 0.009 0.0108 0.6085
Period RRs different from 1994 to 1998? Yes Yes No
p-value <0.0001 <0.0001 0.5487
Period deviation is non-linear? Yes Yes No
p-value 0.0001 0.0002 0.4575
Cohort effect: peak incidence      
Birth cohort years 1922 - 1927 1922 - 1927 1901 - 1906*
Local drifts equal net drift for all age groups? Yes Yes No
p-value <0.0001 <0.0001 0.2076
Cohort RRs different from referent? Yes Yes Yes
p-value <0.0001 <0.0001 0.0216
Non-linear cohort deviation? Yes Yes No
p-value <0.0001 <0.0001 0.1711
Cross-sectional age trend  11.30% 11.80% 7.40%
(95% CI) (10.1 to 12.5) (10.5 to 13.0) (6.2 to 8.7)
Longitudinal age trend  9.80% 9.90% 7.00%
(95% CI) (8.2 to 11.3) (8.1% to 11.8) (5.0% to 9.1)
Longitudinal vs. cross-sectional RR trend Negative Negative Negative/flat
Non-linear age deviation? Yes Yes Yes
p-value <0.0001 <0.0001 <0.0001
*Another non-statistically significant birth cohort incidence peak was noted between 1992 - 1997

Age-period-cohort analysis findings (which utilized SEER12 data) for all mesothelioma in Figures 1 and 2 with error bars indicating 95% confidence intervals. The age-related rate of all mesothelioma by cross-sectional age adjusted for birth cohort and calendar year showed a statistically significant exponential fit between ages 40 and 80 (Figure 1).

Figure 1:

The work cohort rate ratio of all mesothelioma adjusted for age and calendar year showed significantly elevated values for US males entering the workforce between 1920 and 1970, and then became flat and not significantly elevated for six subsequent 5-year nodes of observation (Figure 2).

Figure 2:

For the predominant subset of pleural mesothelioma, ageperiod-cohort analysis findings are similar to those for all mesothelioma as illustrated in Figures 3 and 4. The age-related rate of pleural mesothelioma by cross-sectional age adjusted for birth cohort and calendar year showed a statistically significant exponential fit between ages 40 and 80 (Figure 3).

Figure 3:

The work cohort rate ratio of pleural mesothelioma adjusted for age and calendar year showed significantly elevated values for US males entering the workforce between 1920 and 1970, and then became flat and not significantly elevated for six subsequent 5-year nodes of observation (Figure 4).

Figure 4:

Peritoneal mesothelioma findings based on age-period cohort analysis are distinctly different from those for pleural mesothelioma as illustrated in Figures 5 and 6. In contrast to the more congruent age-related rate trends for all mesothelioma and pleural mesothelioma, the age-related rate of peritoneal mesothelioma by cross-sectional age adjusted for birth cohort and calendar year appears to show different rates for males between age 40 and 55 when compared to rates observed between ages 55 and 80 (Figure 5).

Figure 5:

Similarly in contrast to findings for all mesothelioma and pleural mesothelioma, the work cohort rate ratio of peritoneal mesothelioma adjusted for age and calendar year showed inconsistently elevated values for US males entering the workforce between 1920 and 1950, with apparently flat and not significantly elevated rate ratios for the ten subsequent 5-year nodes of observation for work cohorts after 1950 (Figure 6).

Figure 6:


The current study identified distinct age-, calendar period, and cohort-related effects on all mesothelioma, pleural, and peritoneal mesothelioma incidence trends among US males that are consistent with a prominent influence of high occupational exposures to amosite during the era of World War II. The findings demonstrated different trend patterns between peritoneal mesothelioma incidence and the other two mesothelioma groups, including earlier flattening of peritoneal mesothelioma incidence rates starting in the mid-1950s. This earlier flattening of peritoneal mesothelioma rates may be attributable to nonasbestos etiology of peritoneal mesothelioma, particularly among work cohorts after 1954. Although mesothelioma incidence rates peaked between 1979-1983 for all three groups, only all mesothelioma and pleural mesothelioma showed robustly significant downward trends over the time period of the study (1975-2019). The flattening of all mesothelioma and pleural mesothelioma rates for males entering the US workforce after 1972 suggests the era of prominent risks from occupational asbestos exposure has ended and that the continuing incidence may be attributable to non-asbestos etiologies.

Projections of occupational asbestos-related pleural mesothelioma (and background/non-asbestos cases) have been driven by assumptions of relatively high asbestos exposures to the large US workforce involved in shipbuilding and shipyard repairs in the World War II era [21-23]. A focus on this era is also supported by the more prominent use of amosite for ship insulation [24,4,25], because this amphibole form is a highly potent cause of mesothelioma relative to the chrysotile form that continued to be used in the US until the 1990s [26-28]. The timing of a birth cohort’s first entry into the workforce at age 18 can be simulated by adding 18 years to the birth cohort range. For example, adding 18 years to the male birth cohort range for peak PM incidence (1926-1932 for both age groups) leads to a calendar period (1944-1950) plausibly circumscribing the period of more intense post-World War II shipyard production and ship repair activities. Increasing recognition and control of asbestos hazards and associated declining amosite exposures [24,25], plausibly correspond with reduced pleural mesothelioma incidence among persons with first occupational exposure after the 1950s in US shipyards.

Nuances in the period and birth cohort trends in pleural mesothelioma incidence may also provide useful insights, particularly among males given their more robust data. First, a relatively monotonic decline in pleural mesothelioma incidence rate by calendar period (adjusted for birth cohort effects) is observed in age 0-74 males following the peak in 1978-1982 calendar years and a relatively monotonic decline is observed in this group following the birth cohort peak in 1928-1932 [2]. Adding 18 years to this birth cohort corresponds to an early workforce exposure period of 1946-1950 and an associated latency to peak pleural mesothelioma cohort rate ratio (in 1978-1982) of perhaps 28 to 36 years [2]. This latency range is consistent with other estimates for pleural mesothelioma caused by high occupational exposures to amphibole asbestos among mining and milling workers, shipyard workers, insulators, and pipefitters [8,29-31].

European researchers have reported shifting trends in PM incidence or mortality in the last two decades in Italy [32,33], France [34,35], Belgium [36], Sweden [37], the Netherlands [38], and the United Kingdom [39]. Studies examining agespecific trends are discussed further below. The extent to which these shifting PM trends are due to region-specific variation in occupational asbestos exposures and/or longevity-related factors is currently unknown. The attrition of pleural mesothelioma risk among younger age groups and the shift towards higher age-adjusted risks in older age groups as shown by Kerger [2], is apparent in studies from several European countries. Tan et al. [39] used Bayesian methods to predict peak (total) mesothelioma mortality occurring in 2016 in the UK, with a rapid decline thereafter. Birth cohorts after 1965 showed consistently low numbers of actual and projected mesothelioma deaths, and a steady linear rate of decline was noted for birth cohorts between 1955 and 1965 [39]. Jarvholm and Burdorf [37] reported that age-adjusted pleural mesothelioma mortality trends for all age groups in Sweden tended to mask a strong influence of age among long-surviving individuals from more exposed birth cohorts (e.g., 1935 to 1949) that was offset by the rapidly decreasing rates among younger birth cohorts. Segura et al. [38] reported that an age-cohort model among men in the Netherlands showed the highest age-specific death rates among the oldest age group (age 75 to 84) and the highest relative risks for birth cohorts of 1938 to 1947. Segura et al. [38] noted that the strong increase in male pleural mesothelioma incidence between 1969 and 1998 may be affected by increasing diagnostic awareness of mesothelioma since the late 1970s.

Like previous analyses which showed that age-adjusted peritoneal mesothelioma rates for men exhibited no temporal trends from 1973 to 2005 [3], this study did not show any temporal trends using SEER-8 data from 1975 to 2019. Other authors recently reported analyses results limited to SEER-18 (2000 – 2018) data and reported that although specific histology showed significant incidence trends, the age-adjusted incidence of peritoneal mesothelioma was similarly stable over the period [40]. Multiple asbestos cohorts have also been investigated for peritoneal mesothelioma outcomes trends with demonstrated non-elevated, flat, or declining rates in populations in Norway [41], Sweden [42], Denmark [43], and mortality risk in Italy [44].


The current study identifies distinct age- and cohort-related effects on all mesothelioma, pleural, and peritoneal mesothelioma incidence trends among US males that are consistent with a prominent influence of high occupational exposures to amosite during the era of World War II. These findings suggest that the cohort of US males first entering the workforce after 1972 show no increased incidence of mesothelioma (all, pleural, or peritoneal). This may be related to the impacts of occupational asbestos regulations starting in 1972 in addition to plausible threshold-dependent risks from chrysotile which continued to be used through the 1990s. In contrast, US males first entering the workforce after 1954 showed an earlier flattening of peritoneal mesothelioma rates compared to pleural or all mesothelioma. The flattening of work cohort mesothelioma rates after 1972 suggests the era of prominent risks from occupational asbestos exposure has ended; continuing incidence may be attributable to non-asbestos etiologies.

This age-period-cohort analysis is limited by use of the less robust SEER-8 database, by the relative low incidence of mesothelioma generally, and more specifically, by the ten-fold lower incidence of peritoneal mesothelioma. However, the findings reported for all mesothelioma and pleural mesothelioma are reasonably robust for SEER-8 and attempts to include additional SEER registry data (e.g., SEER-12 or the currently available SEER-17) could introduce positive or negative bias that would be difficult to interpret. In addition, the SEER database does not include information on occupational exposures to asbestos or other carcinogens, making the interpretation of mesothelioma trends indirect and dependent on other information and data sources.

The authors recommend continued surveillance of the SEER database trends for mesothelioma to assess whether the trends observed in this study continue with the expanding robustness of observations for work cohorts after 1972. It is also recommended that non-asbestos sources be considered more diligently for continuing incidence of mesothelioma in the United States.


This work was funded internally by Exponent, Inc. and no outside party participated in the design, data analysis, interpretation, or writing of this manuscript. Two of the authors (BDK and AEL) are current employees of Exponent, Inc., a scientific consulting firm that provides research and advice to private sector and government clients. One author (NO) is a former employee of Exponent, Inc. and self-funded his contributions to this work. One author (BDK) has testified in US courts as a toxicology expert retained by private clients in asbestos litigation.


Ethics Approval and Consent to Participate

Access to the SEER-12 database was obtained after execution of the SEER data use agreement at: https://seer.cancer.gov/ dataagreements/seer.pdf. The data analyses and use of the SEER-12 database in this manuscript is in accordance with the data use agreement and does not require Institutional Review Board approval or other ethics approval or consent of the study subjects.

Consent for Publication

The cancer incidence data contained in this manuscript was analyzed and used in accordance with the SEER data use agreement and therefore does not require separate consent for publication.

Availability of Data and Materials

The SEER-12 cancer incidence data analyzed in this manuscript is publicly available but is subject to a signed data use agreement which forbids sharing the underlying data files. The NCI webtool for Age-Period-Cohort analysis is also a publicly available program which other researchers may access and apply to the SEER-12 data (within the SEER data use agreement guidelines) to further analyze and/or validate the analyses presented here.

Author’s Contributions

Two of the authors (BDK and AEL) designed the study, analyzed the scientific literature, interpreted the analytical findings of the age-period-cohort analysis performed by the epidemiologist author (NO), and drafted the manuscript. All three authors provided further revisions to complete the final manuscript and approved it for submission.


The authors would like to thank Ellen Chang for assistance with earlier statistical analyses and peer review of the draft manuscript.


1. Kerger BD, James RC, Galbraith DA. Tumors that mimic asbestosrelated mesothelioma: Time to consider a genetics-based tumor registry? Front Genet. 2014; 5: 1-14.

2. Kerger BD. Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973-2013. BMC Res Notes. 2018; 11: 337.

3. Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes Control. 2009; 20: 935-44.

4. Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US Mesothelioma patterns 1973-2002: Indicators of change and insights into background rates. Eur J Cancer Prev. 2008; 17: 525-534.

5. Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009; 39: 576-88.

6. Mezei G, Chang ET, Mowat FS, Moolgavkar SH.Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol. 2017; 27: 348-359 e311.

7. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant Mesothelioma and Its Non-Asbestos Causes. Arch Pathol Lab Med. 2018; 142: 753-760.

8. Neumann V, Gunthe S, Mulle KM, Fischer M. Malignant mesothelioma-- German mesothelioma register 1987-1999. Int Arch of Occup Environ Health. 2001; 74: 383-95.

9. McDonald JC, Harris JM, Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med. 2006; 63: 852-5.

10.Pass HI, Hahn SM, Vogelzang NJ, Carbone M. Benign and malignant mesothelioma, in Cancer, Principles and Practice of Oncology, 8th Ed. VT DeVita, TS Lawrence, SA Rosenberg (Philadelphia: Lippincottt,Williams, and Wilkins). 2005; 1687–1750.

11.Boffetta P, Stayner LT.Pleural and peritoneal neoplasms. In: Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF, Oxford Univ. Press London. 2006; 659-673.

12.Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007; 18: 985-90.

13.Berry G, de Klerk NH, Reid A, Ambrosini GL, Fritschi L, Olsen NJ, et al. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med. 2004; 61: e14.

14.Reid A, de Klerk N, Ambrosini G, Olsen N, Pang SC, Musk AW. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med. 2005; 62: 665-9.

15.Pira E, Pelucchi C, Buffoni L, Palmas A, Turbiglio M, Negri E, Piolatto PG, La Vecchia C. Cancer mortality in a cohort of asbestos textile workers. Br J Cancer. 2005; 92: 580-6.

16.Magnani C, Ferrante D, Barone-Adesi F, Bertolotti M, Todesco A, Mirabelli D, et al. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers. Occup Environ Med. 2007; 65: 164-70.

17.Hilliard AK, Lovett JK, McGavin CR. The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979-1999. Occup Med (Lond). 2003; 53: 209-12.

18.Coggon D, Inskip H, Winter P, Pannett B. Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. Occup Environ Med. 1995; 52: 775-7.

19.Sporn TA, Roggli VL. Mesothelioma, in Pathology of AsbestosAssociated Diseases, 2nd Ed., VL Roggli, TD Oury, TA Sporn. NewYork, NY: Springer. 2004; 104–168.

20.Rosenberg PS, Check DP, Anderson WF. A web tool for age-periodcohort analysis of cancer incidence and mortality rates.Cancer Epidemiol Biomarkers Prev. 2014; 23: 2292-2302.

21.Lilienfeld DE, Mandel JS, Coin P, Schuman LM. Projection of asbestos related disease in the United States, 1985-2009 I. Cancer. Brit J Indust Med. 1988; 45; 283-291.

22.Walker AM Loughlin JE, Friedlander ER, Rothman KJ, Dreyer NA. Projections of asbestos-related disease 1980-2009. J Occup Med. 1983; 25: 409-425.

23.Nicholson WJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality--1980-2030. Am J Indust Med. 1982; 3: 259-311.

24.Franke K, Paustenbach D. Government and Navy knowledge regarding health hazards of asbestos: a state of the science evaluation (1900 to 1970). Inhal Toxicol. 2011; 3: 1-20.

25.Rushworth DH. The Navy and asbestos thermal insulation. Naval Eng J. 2005; 117: 35-48.

26.Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000; 44: 565-601.

27.Berman DW, Crump KS. A Meta-Analysis of Asbestos-Related Cancer Risk that Addresses Fiber Size and Mineral Type. Crit Rev Toxicol. 2008a; 38: 49-73.

28.Berman DW, Crump KS. Update of Potency Factors for Asbestos Related Lung Cancer and Mesothelioma. Crit Rev Toxicol. 2008b; 38: 1-47.

29.Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C.Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997; 6: 162-166.

30.Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992; 34: 718-721.

31.Selikoff IJ, Cuyler E, Hammond EC, Seidman H.Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 1980; 46: 2736-2740.

32.Girardi P, Bressan V, Merler E. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region. Cancer Epidemiol. 2014; 38: 496-503.

33.Mensi C, De Matteis S, Dallari B, Riboldi L, Bertazzi PA, Consonni D. Indicence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections. Occup Environ Med. 2016; 73: 607-613.

34.Lacourt A, Leffondre K, Gramond C, Ducamp S, Rolland P, Gilg Soit Ilg A, et al. Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma. Eur Respir J. 2012; 39: 1304-1312.

35.Le Stang N, Belot A, Gilg Soit Ilg A, Rolland P, Astoul P, Bara S, et al. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer. 2010; 126: 232-238.

36.Van den Borre L, Deboosere P.Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969- 2009). Int J Occup Environ Health. 2014; 20: 134-140.

37.Jarvholm B, Burdorf A. Emerging evidence that the ban on asbestos use is reducing occurrence of pleural mesothelioma in Sweden. Scan J Public Health. 2015; 43: 875-881.

38.Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003; 60: 50-55.

39.Tan E, Warren N, Darnton AJ, Hodgson JT. Projection of mesothelioma mortality in Britain using Bayesian methods. Brit J Cancer. 2010; 103: 430-436.

40.Calthorpe L, Alseidi A, Abdelgadir Adam M. ASO author reflections: Contemporary management trends in malignant peritoneal mesothelioma. Ann Surg Oncol. 2023; 30: 5130.

41.Ulvestad B, Kjaerheim K, Moller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1000. Int J Cancer. 2003; 107: 94-98.

42.Hemminki K, Li X. Time trends and occupational risk factors for peritoneal mesothelioma in Sweden. J Occup Environ Med. 2003; 45: 451-5.

43.Andersson M, Olsen JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer 1985; 51: 699-705.

44.Oddone E, Bollon J, Rubina Nava C, Consonni D, Marinnaccio A, Magnani C, et al. Effect of asbestos consumption on malignant pleural meosthelioma in Italy: Forecases of mortality up to 2040. Cancers (Basel). 2021; 13: 3338.

Kerger BD, Odo NU, Loccisano AE (2023) Age-Period-Cohort Analysis of Mesothelioma: Flat Incidence Trends for Males Entering US Workforce After 1972. Ann Clin Pathol 10(1): 1165.

Received : 03 Jul 2023
Accepted : 31 Jul 2023
Published : 31 Jul 2023
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X